radioligand therapy
Showing 26 - 50 of >10,000
Microglia in the Pathogenesis of Progressive Multiple Sclerosis
Active, not recruiting
- Multiple Sclerosis
-
Turku, Finland Proper, FinlandTurku PET Centre
Oct 12, 2022
Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Esophageal Cancer Trial in Toronto ([Ga-68]-PNT6555, [Lu-177]-PNT6555)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +4 more
-
Toronto, Ontario, CanadaUniversity Health Network - Princess Margaret Cancer Centre
Aug 16, 2022
Metastatic Castration-resistant Prostate Cancer Trial in Beijing (1.11GBq of 177Lu-EB-PSMA-617, 2.00 GBq of 177Lu-EB-PSMA-617,
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- 1.11GBq of 177Lu-EB-PSMA-617
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
May 6, 2022
Metastatic Prostate Cancer Trial in Nanjing (177Lu-PSMA-0057)
Recruiting
- Metastatic Prostate Cancer
-
Nanjing, Jiangsu, ChinaNanjing First Hospital
Sep 17, 2023
Salivary Gland Cancer, Salivary Duct Carcinoma Trial in Nijmegen (68Ga-PSMA-PET/CT, 18FDG-PET/CT)
Recruiting
- Salivary Gland Cancer
- Salivary Duct Carcinoma
- 68Ga-PSMA-PET/CT
- 18FDG-PET/CT
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Aug 15, 2022
Prostate Cancer Metastatic, Castration Resistant Prostatic Cancer, Advanced Prostate Carcinoma Trial in Homburg
Recruiting
- Prostate Cancer Metastatic
- +2 more
-
Homburg, Saarland, GermanyDept. of Nuclear Medicine, Saarland University
Apr 4, 2021
Newly Diagnosed Glioblastoma Trial ([177Lu]Lu-NeoB, [68Ga]Ga-NeoB, Temozolomide)
Not yet recruiting
- Newly Diagnosed Glioblastoma
- [177Lu]Lu-NeoB
- +2 more
- (no location specified)
Feb 13, 2023
Cancer Trial in Meldola, Cesena ([177Lu]Lu-PSMA I&T)
Not yet recruiting
- Cancer
- [177Lu]Lu-PSMA I&T
-
Meldola, Forlì, Italy
- +1 more
May 10, 2023
Prostate Cancer Trial in Vancouver, Montreal, Quebec City (177Lu-PSMA-617, Docetaxel)
Suspended
- Prostate Cancer
-
Vancouver, British Columbia, Canada
- +3 more
Jun 13, 2022
Metastatic Castration-Resistant Prostate Cancer Trial in Worldwide ([Lu-177]-PNT2002, Abiraterone, Enzalutamide)
Recruiting
- Metastatic Castration-Resistant Prostate Cancer
- [Lu-177]-PNT2002
- +2 more
-
Tucson, Arizona
- +47 more
Jun 1, 2022
Prostate Cancer, Localized Prostate Carcinoma Trial (PSMA-1007 Positron Emission Tomography (PET) scan)
Not yet recruiting
- Prostate Cancer
- Localized Prostate Carcinoma
- PSMA-1007 Positron Emission Tomography (PET) scan
- (no location specified)
Aug 14, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Stage IVB Prostate Cancer AJCC v8 Trial in San
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Radium-223
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jun 20, 2023
Metastatic Prostate Cancer, Castration-resistant Prostate Cancer, Prostatic Tumor Trial in Canada, United States (I-131-1095,
Active, not recruiting
- Metastatic Prostate Cancer
- +4 more
-
Duarte, California
- +26 more
Aug 3, 2022
Advanced Solid Tumor, Metastatic Colorectal Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Irvine, Chicago, Boston
Not yet recruiting
- Advanced Solid Tumor
- +4 more
- FPI-2053
- +2 more
-
Irvine, California
- +2 more
Nov 27, 2023
Breast Cancer Trial in Madison (drug, device, other)
Not yet recruiting
- Breast Cancer
- 18F-fluorofuranylnorprogesterone
- +4 more
-
Madison, WisconsinUW Carbone Cancer Center
Oct 11, 2023
HIV Associated Neurocognitive Disorder, HIV Dementia, HIV Encephalitis Trial (SV2A PET, TSPO PET)
Not yet recruiting
- HIV Associated Neurocognitive Disorder
- +3 more
- SV2A PET
- TSPO PET
- (no location specified)
Oct 16, 2022
Measuring Active Microglia in Progressive Multiple Sclerosis
Completed
- Secondary Progressive Multiple Sclerosis
- [C11]PK-1195 PET scan
-
New York, New YorkWeill Cornell Medical College
Jan 14, 2022
Prostate Cancer Trial in Bern (18F-PSMA-1007, 68Ga-PSMA-11)
Recruiting
- Prostate Cancer
- 18F-PSMA-1007
- 68Ga-PSMA-11
-
Bern, SwitzerlandInselspital, Universitätsspital Bern
Jul 4, 2022
Prostate Cancer Trial in Québec (Enzalutamide capsule)
Recruiting
- Prostate Cancer
- Enzalutamide capsule
-
Québec, CanadaCHU de Québec-Université Laval
Mar 29, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San Francisco
Recruiting
- Castration-Resistant Prostate Carcinoma
- +4 more
- 68Ga-PSMA-11
- Positron Emission Tomography (PET)
-
San Francisco, CaliforniaUniversity of California San Francisco
Feb 27, 2022
Germ Cell Tumor, Seminoma, Nonseminomatous Germ Cell Tumor Trial in Duesseldorf (Robot-assisted ICG-guided sentinel lymph node
Recruiting
- Germ Cell Tumor
- +2 more
- Robot-assisted ICG-guided sentinel lymph node biopsy
-
Duesseldorf, GermanyUniversity Hospital of Duesseldorf
Nov 10, 2023
Prostate Cancer Trial ([177Lu]Lu-PSMA I&T, Stereotactic Radiotherapy)
Not yet recruiting
- Prostate Cancer
- [177Lu]Lu-PSMA I&T
- Stereotactic Radiotherapy
- (no location specified)
May 30, 2023
Neurodegenerative Diseases, Parkinson Disease, Parkinson Disease Psychosis Trial (Pimavanserin)
Recruiting
- Neurodegenerative Diseases
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Jan 24, 2023